optisulin solostar 100iu/ml insulin glargine (rbe) 3ml solution for injection injector pen
sanofi-aventis australia pty ltd - insulin glargine, quantity: 3.6378 mg/ml - injection, solution - excipient ingredients: water for injections; metacresol; glycerol; zinc chloride; sodium hydroxide; hydrochloric acid - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for control of hyperglycaemia.
optisulin 100iu/ml insulin glargine (rbe) 3ml solution for injection cartridge
sanofi-aventis australia pty ltd - insulin glargine, quantity: 3.6378 mg/ml - injection, solution - excipient ingredients: metacresol; sodium hydroxide; zinc chloride; glycerol; hydrochloric acid; water for injections - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for control of hyperglycaemia.
lantus solostar 100iu/ml insulin glargine (rbe) 3ml solution for injection injector pen
sanofi-aventis australia pty ltd - insulin glargine, quantity: 3.6378 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; metacresol; zinc chloride; glycerol - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for control of hyperglycaemia.
semglee insulin glargine (rdna) 100 iu/ml, 3 ml solution for injection injector pen
maxx pharma pty ltd - insulin glargine, quantity: 100 u/ml - injection, solution - excipient ingredients: sodium hydroxide; glycerol; water for injections; hydrochloric acid; metacresol; zinc chloride - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for the control of hyperglycaemia.
kiovig normal immunoglobulin (human) 5g/50ml solution for injection vial
takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 100 mg/ml - injection, solution - excipient ingredients: water for injections; glycine; human immunoglobulin a - kiovig administered intravenously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid);,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. immunomodulation indications,? idiopathic thrombocytopenia purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;,? guillain barr? syndrome;,? kawasaki disease;,? chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in adults.,? multifocal motor neuropathy (mmn).,kiovig administered subcutaneously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid).
kiovig normal immunoglobulin (human) 2.5g/25ml solution for injection vial
takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 100 mg/ml - injection, solution - excipient ingredients: water for injections; human immunoglobulin a; glycine - kiovig administered intravenously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid);,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. immunomodulation indications,? idiopathic thrombocytopenia purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;,? guillain barr? syndrome;,? kawasaki disease;,? chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in adults.,? multifocal motor neuropathy (mmn).,kiovig administered subcutaneously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid).
nutrineal solution for peritoneal dialysis 4 with 1.1% amino acids
baxter healthcare limited - sodium chloride; l-histidine; l-tryptophan; l-arginine; l-valine; l-tyrosine; sodium (s)-lactate solution; l-lysine hydrochloride; l-leucine; l-isoleucine; l-proline; glycine; l-phenylalanine; l-threonine; l-serine; l-methionine; l-alanine; magnesium chloride; calcium chloride - solution for peritoneal dialysis - 1.1 percent - hypertonic solutions
physioneal 40 glucose 1.36% w/v / 13.6 mg/ml solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium bicarbonate; sodium (s)-lactate solution - solution for peritoneal dialysis - 1.36 percent weight/volume - hypertonic solutions
albunorm 20% solution for infusion 200g/l
octapharma (ip) limited - human albumin solution - solution for infusion - human albumin solution 200 g/l - blood substitutes and perfusion solutions
albunorm 5%, 50g/l, solution for infusion
octapharma (ip) limited - human albumin solution - solution for infusion - human albumin solution 50 g/l - blood substitutes and perfusion solutions